{
  "url": "https://www.moneycontrol.com/news/business/ipo/veterinary-solutions-provider-rodec-pharma-files-ipo-papers-with-no-fresh-issue-component-13769367.html",
  "scraped_at": "2026-01-19T15:18:00.176518",
  "title": "Veterinary solutions provider Rodec Pharma files IPO papers with no fresh issue component",
  "published_date": "January 12, 2026/ 22:39 IST",
  "author": "Moneycontrol News",
  "content": "Uttar Pradesh-based veterinary pharmaceutical company Rodec Pharma has filed draft document with capital markets regulator SEBI to raise funds via Initial Public Offering (IPO) with no fresh issue component.\n\nThe IPO will be entirely an offer-for-sale of 56.5 lakh shares by promoter Mukesh Kumar Gupta. Hence, the company will not receive any funds from the offer.\n\nThe main objects of the public issue are to carry out the offer-for-sale, and achieve the benefits of listing equity shares on stock exchange.\n\nIncorporated in 1997, Rodec Pharma that manufactures animal feed supplements and markets veterinary pharmaceutical drugs and animal feed supplements to veterinarians, animal healthcare providers, and livestock farmers has manufacturing facility in Ghaziabad, Uttar Pradesh.\n\nThe animal feed supplements business contributed around 40 percent of the company’s revenue, while pharmaceutical drugs—such as analgesics and antipyretics, anthelmintics, and antibiotics—accounted for about 55 percent of the topline.\n\nClick Here To ReadAll IPO News\n\nThe company recorded profit of Rs 9.7 crore on revenue of Rs 62.7 crore for six months period ended September 2025. Further, profit in fiscal 2025 grew by 65.4 percent to Rs 18.3 crore, up from Rs 11 crore in previous year, while revenue during the same period increased 20.3 percent to Rs 106.4 crore, up from Rs 88.4 crore.\n\nKhambatta Securities is appointed as the merchant banker for the Rodec Pharma IPO.",
  "content_length": 1463,
  "tags": [],
  "category": "business"
}